Hypertension

British Medical Journal

Volumn 314, Issue 7089, 1997, Pages 1258-1261

  Brown, Morris J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; ENVIRONMENTAL FACTOR; ESSENTIAL HYPERTENSION; HEREDITY; HUMAN; HYPERTENSION; KIDNEY FAILURE; PRIORITY JOURNAL; SHORT SURVEY; STROKE; UNITED KINGDOM; UNITED STATES; GENETIC PREDISPOSITION; GENETICS; REVIEW;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION;

EID: 0031586885     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (27)

1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J. Blood pressure, stroke, and coronary heart disease: part I, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335: 765-74.
2. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood-pressure control in the hypertensive population. Lancet 1997;349:454-7.
3. Lifton RP. Molecular genetics of human blood pressure variation. Science 1996;272:676-80.
4. Brown MJ, Brown J. Does angiotensin-II protect against strokes? Lancet 1986;ii:427-9.
5. Brown MJ. The causes of essential hypertension. Br J Clin Pharmacol 1996;42:21-7.
6. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992;10:1025-31.
7. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-42.
8. Hingorani AD, Liang CF, Fatibene J, Parsons A, Hopper R, Brown MJ, et al. A common variant of the endothelial nitric oxide synthase gene is a major risk factor in East Anglia for coronary atherosclerosis. Q J Med (in press).
9. Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Brown MJ, et al. A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma. Comparison of level in patients with essential hypertension and normotensive control subjects. Clin Sci 1990;78:261-4.
10. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994;368:703-10.
11. Stevens PA, Brown MJ. Genetic variability of the ET-1 and the ETA receptor genes in essential hypertension. J Cardiovasc Pharmacol 1995;26 (suppl 3):S9-12.
12. Sharma P, Hingorani AD, Jia H, Stevens P, Hopper R, Brown MJ. Quantitative association between a newly identified polymorphism in the endothelin-2 gene and essential hypertension. Clin Sci 1996;90:2p.
13. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-80.
14. Hingorani AD, Sharma P, Jia H, Hopper R, Brown MJ. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 1996;28:907-11.
15. Cusi D, Bianchi G, Tripodi G, Casari G, Salardi S, Barber BR, et al. Renal mechanisms of genetic hypertension: from the molecular level to the intact organism. Kidney Int 1994;91:3999-4003.
16. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-8.
17. Pennisi E. From genes to genome biology. Science 1996;272:1736-8.
18. Smith WC, Lee AJ, Crombie IK, Tunstall Pedoe H. Control of blood pressure in Scotland: the rule of halves. BMJ 1990;300:981-3.
19. Rubattu S, Volpe M, Kreutz R, Ganten U, Ganten D, Lindpaintner K. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nature Genet 1996;13:429-34.
20. Levy BI, Poitevin P, Duriez M, Guez DC, Schiavi PD, Safar ME. Sodium, survival, and the mechanical properties of the carotid artery in stroke-prone hypertensive rats. J Hypertens 1997;15:251-8.
21. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A meta-analysis of 109 treatment studies. Am J Hypertens 1992;5:95-110.
22. MRC Working Party. Course of blood pressure in mild hypertensives after withdrawal of long term ami hypertensive treatment. BMJ 1986;293:988-92.
23. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994;50:272-98.
24. Mulvany MJ. Resistance vessel structure and the pathogenesis of hypertension. J Hypertens 1993;11(suppl 5):S7-12.
25. Godfrey KM, Barker DJP, Peace J, Cloke J, Osmond C. Relation of fingerprints and shape of palm to fetal growth and adult blood pressure. BMJ 1993;307:405-8.
26. Sulivan JM, Prewitt RL, Josephs JA. Attenuation of the microcirculation in young patients with high-output borderline hypertension. Hypertension 1983;5:844-51.
27. Churchill D, Perry IJ, Beevers DG. Ambulatory blood pressure in pregnancy and fetal growth. Lancet 1997;349:7-10.